Kilitch Drugs (India) is one of the leading companies in the development, manufacturing, marketing, and exporting of a wide range of pharmaceutical formulations. Furthermore, the company, a varied pharmaceutical company, was founded in 1978. The company has a strong reputation overseas as various products have been sold there, such as Africa, Asia, the CIS, and Latin America, and strategic focus on Africa. In those countries, the cephalosporin manufacturing facility in Ethiopia is producing tablets, capsules, injectables, and dry powders. The company has factories in India and Ethiopia, and its new Khopoli plant will make diabetes and weight-loss medicines, plus biosimilars, with plans to get US and EU approvals later.
Kilitch Drugs (india) Rights Issue Review
- N/A
Kilitch Drugs (india) Rights Issue 2025 Dates & Time Table
| Rights Issue Open: | July 23, 2025 |
| Rights Issue Close: | August 21, 2025 |
| Rights Record Date: | July 15, 2025 |
| Last Date to Buy Shares: | July 14, 2025 |
| Deemed Date of Allotment | August 22, 2025 |
| Renunciation of Rights Entitlements | August 18, 2025 |
Kilitch Drugs (india) Rights Issue 2025 Offer Details
| Rights Issue Size: | Approx ₹49.93 Crores |
| Price Band: | ₹357 Per Equity Share |
| Face Value: | ₹10 Per Equity Share |
| Listing on: | BSE, NSE |
| Entitlement Ratio: | 2:23 (2 rights share for every 23 shares) |
| Equity: | 13,98,463 Equity Share |
| Letter of Offer: | Click Here |
| Application Form: | Click Here |
| Live Share Price: | Click Here |
Kilitch Drugs (india) Rights Issue 2025 Form & How to Apply
You can apply for Kilitch Drugs (india) Rights Issue 2025 in two ways:
- Net Banking (ASBA)
- Registrar’s Website (R-WAP Facility)
Kilitch Drugs (india) Financial Report
| ₹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2023 | ₹122.38 | ₹102.93 | ₹15.72 |
| 2024 | ₹137.79 | ₹114.43 | ₹17.57 |
| 2025 | ₹195.30 | ₹154.61 | ₹31.16 |
Kilitch Drugs (india) Rights Issue 2025 Allotment Status
MUFG Intime India Private Limited
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Kilitch Drugs (india) Rights Issue 2025 Lead Managers
- To Be Updated Soon
Company Address:
Kilitch Drugs (india) Ltd.
C-301/2 MIDC,
TTC Industrial Area,
Pawane Village, Thane,
Mumbai, 400705
Phone: 02261214100
Email: [email protected]
Website: https://kilitch.com/
Kilitch Drugs (india) Rights Issue 2025 FAQs:
When is Kilitch Drugs (india) Rights Issue 2025 Record Date?
What is Kilitch Drugs (india) Rights Issue 2025 Price?
What is the Kilitch Drugs (india) Rights Issue 2025 Ratio?
How to apply for Kilitch Drugs (india) Rights Issue 2025?
Follow IPO Watch for the Upcoming IPO News and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.
